IIN Supplement Safety & Efficacy 3 — Questions and Answers
Question 1: A practitioner recommends high-dose vitamin D supplementation without first testing a client's serum 25(OH)D levels. What is the primary risk of this approach?
- Vitamin D toxicity causing hypercalcemia (Correct answer)
- Vitamin D deficiency worsening due to supplementation
- Inhibition of parathyroid hormone production causing bone loss
- Increased risk of kidney stones due to phosphorus accumulation
Correct answer: Vitamin D toxicity causing hypercalcemia
Vitamin D toxicity (hypervitaminosis D) causes hypercalcemia, which can lead to nausea, weakness, frequent urination, kidney stones, and in severe cases, cardiac arrhythmias.
Question 2: Standardized herbal extracts are considered advantageous over non-standardized because they:
- Are always more potent and require smaller doses
- Guarantee a consistent level of active constituent(s) per dose (Correct answer)
- Have undergone FDA approval for therapeutic claims
- Contain only synthetic versions of the active compounds
Correct answer: Guarantee a consistent level of active constituent(s) per dose
Standardization ensures each batch of an herbal extract contains a specified percentage of the key active compound(s), providing dosing consistency and reproducibility.
Question 3: Which supplement interaction could be life-threatening for a client taking an SSRI antidepressant?
- Adding magnesium glycinate
- Adding 5-HTP or high-dose tryptophan (Correct answer)
- Adding coenzyme Q10
- Adding B-complex vitamins
Correct answer: Adding 5-HTP or high-dose tryptophan
Combining SSRIs with 5-HTP or tryptophan can cause serotonin syndrome, a potentially fatal condition characterized by agitation, rapid heart rate, high temperature, and muscle rigidity.
Question 4: The Dietary Supplement Health and Education Act (DSHEA) of 1994 placed the primary burden of proving supplement safety before marketing on:
- The FDA
- Independent third-party labs
- The supplement manufacturer (Correct answer)
- The prescribing healthcare provider
Correct answer: The supplement manufacturer
DSHEA shifted the regulatory burden so that manufacturers are responsible for ensuring their products are safe before marketing, without prior FDA approval.
Question 5: A client who is pregnant asks about taking licorice root supplements for digestive support. Your best response is:
- It is safe and effective for morning sickness during all trimesters
- High amounts of glycyrrhizin in licorice are contraindicated in pregnancy due to risks of preterm labor and developmental effects (Correct answer)
- It is only unsafe in the first trimester but safe thereafter
- Licorice root is an FDA-approved remedy for pregnancy-related nausea
Correct answer: High amounts of glycyrrhizin in licorice are contraindicated in pregnancy due to risks of preterm labor and developmental effects
Glycyrrhizin in licorice root can increase cortisol levels, elevate blood pressure, and has been associated with preterm birth and adverse neurodevelopmental outcomes in offspring.
Question 6: When evaluating a clinical study on a supplement, which study design provides the highest level of evidence for efficacy?
- An expert consensus opinion
- A case report series
- A randomized, double-blind, placebo-controlled trial (RCT) (Correct answer)
- An observational cohort study
Correct answer: A randomized, double-blind, placebo-controlled trial (RCT)
RCTs with blinding and randomization minimize selection bias and placebo effects, providing the strongest evidence for a direct causal relationship between a supplement and its outcomes.
Question 7: Which mineral supplement is most commonly associated with gastrointestinal side effects such as diarrhea and nausea, particularly at high doses?
- Zinc
- Selenium
- Magnesium (oxide form) (Correct answer)
- Chromium
Correct answer: Magnesium (oxide form)
Magnesium oxide has poor absorption and draws water into the intestines via osmotic effect, commonly causing loose stools and diarrhea at higher doses.
A practitioner recommends high-dose vitamin D supplementation without first testing a client's serum 25(OH)D levels.
What is the primary risk of this approach?